News

David Browning Becomes Chief Operating Officer (COO) of Medelis

We're excited to announce that David Browning, formerly our…
Read Article

Bill Taaffe Joins Medelis as President

Medelis is pleased to announce that Bill Taaffe,…
Read Article

FDA Guidance Finalizes Position on In Vitro Companion Diagnostic Devices

As more targeted therapies are developed - defined…
Read Article

Medelis Partners With Insight Genetics to Deliver Molecular Diagnostics to Oncology Sponsors and Patients

Increasing the effectiveness of cancer treatments is an…
Read Article

The PD-1 Era Is Officially Here

On July 4th Ono Pharmaceuticals announced that it…
Read Article

Medelis Adds Marketing MO Co-founder Jim Sagar to Board of Directors

Medelis, Inc. today announced that Jim Sagar, CEO of…
Read Article

In Memory of Robert T. Bosserman

Medelis Inc. is deeply saddened to announce the…
Read Article

FDA Breakthrough Therapy Designation: A Pathway for Expedited Drug Development

On July 9, 2012 the Food and Drug…
Read Article

Medelis co-founder Daniel Von Hoff receives prestigious ASCO scientific honor

We are pleased to share the news that…
Read Article